Trademark: 86843003
Word
DERMASEQ
Status
Dead
Status Code
602
Status Date
Tuesday, September 27, 2016
Serial Number
86843003
Mark Type
3000
Filing Date
Tuesday, December 8, 2015
Abandoned Date
Tuesday, September 27, 2016

Trademark Owner History

Classifications
42 Medical and scientific research in the fields of cutaneous T-cell lymphoma and skin-related cancers and diagnosing and treating same; scientific research, development, engineering, testing, and analytical services for diagnosing and treating cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for diagnosing cutaneous T-cell lymphoma and skin-related cancers; providing analysis, evaluation, and clinical reports of a patient's condition with regard to cutaneous T-cell lymphoma and skin-related cancers; providing diagnostic assays and diagnostic or prognostic testing for cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly; research and development of diagnostic test kits for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; laboratory research and testing services relating to detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers; computer services, namely, software as a service (SAAS) services featuring software that provides information, test results for detecting and diagnosing cutaneous T-cell lymphoma and skin-related cancers, and the analysis, evaluation, and reporting of those test results to healthcare professionals to determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly
44 Medical services; medical analysis and diagnostic services; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; providing medical diagnostic testing for the detection, diagnosis, and treatment of cutaneous T-cell lymphoma and skin-related cancers; providing medical testing for immune responses to immunotherapy or cancer treatment
Color is not claimed as a feature of the mark.
The mark consists of The mark consists of the word "dermaSEQ," with the term "derma" in lower case and the term "SEQ" in uppercase and the "Q" in "SEQ" is meant to appear as a magnifying glass and has a glint/reflection mark inside the letter.
DERMA SEQ

Trademark Events
Feb 13, 2018
Teas Change Of Correspondence Received
Sep 27, 2016
Abandonment Notice Mailed - Failure To Respond
Sep 27, 2016
Abandonment - Failure To Respond Or Late Response
Mar 25, 2016
Notification Of Non-Final Action E-Mailed
Mar 25, 2016
Non-Final Action E-Mailed
Mar 25, 2016
Non-Final Action Written
Mar 24, 2016
Assigned To Examiner
Dec 12, 2015
Notice Of Design Search Code E-Mailed
Dec 11, 2015
New Application Office Supplied Data Entered In Tram
Dec 11, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24